Highlighted Paper selected by Editor-in-Chief : Development of Probiotic Formulation for the Treatment of Iron Deficiency Anemia
-
- Korčok Davor Jovan
- Department of Research and Development Abela Pharm
-
- Tršić-Milanović Nada Aleksandar
- Department of Research and Development Abela Pharm
-
- Ivanović Nevena Djuro
- Department of Bromatology, Faculty of Pharmacy, University of Belgrade
-
- Đorđević Brižita Ivan
- Department of Bromatology, Faculty of Pharmacy, University of Belgrade
書誌事項
- タイトル別名
-
- Development of Probiotic Formulation for the Treatment of Iron Deficiency Anemia
この論文をさがす
説明
<p>Probiotics are increasingly more present both as functional foods, and in pharmaceutical preparations with multiple levels of action that contribute to human health. Probiotics realize their positive effects with a proper dose, and by maintaining a declared number of probiotics cells by the expiration date. Important precondition for developing a probiotic product is the right choice of clinically proven probiotic strain, the choice of other active components, as well as, the optimization of the quantity of active component of probiotic per product dose. This scientific paper describes the optimization of the number of probiotics cells in the formulation of dietary supplement that contains probiotic culture Lactobacillus plantarum 299v, iron and vitamin C. Variations of the quantity of active component were analyzed in development batches of the encapsulated probiotic product categorized as dietary supplement with the following ingredients: probiotic culture, sucrosomal form of iron and vitamin C. Optimal quantity of active component L. plantarum of 50 mg, was selected. The purpose of this scientific paper is to select the optimal formulation of probiotic culture in a dietary supplement that contains iron and vitamin C, and to also determine its expiration date by the analysis of the number of viable probiotic cells.</p>
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 66 (4), 347-352, 2018
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204177862528
-
- NII論文ID
- 130006601992
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 028907227
-
- PubMed
- 29353864
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可